The pharmaceutical industry relies heavily on a robust supply of chemical intermediates to facilitate the large-scale production of medicines. 2-Butyrylaminopropionic Acid (CAS 55930-29-5), with its characteristic white powder appearance, serves as a critical bulk drug intermediate, underpinning many manufacturing processes. NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role in this sector by ensuring the consistent availability and quality of this essential compound.
As a bulk drug intermediate, 2-Butyrylaminopropionic Acid is not an end product itself but a crucial component in the multi-step synthesis of various active pharmaceutical ingredients (APIs). Its chemical structure, derived from the combination of alanine and butyric acid, provides the necessary functional groups for further chemical modifications. The efficiency and reliability of its synthesis, whether through established methods or novel approaches, directly impact the downstream production of pharmaceuticals. Information on its properties, such as melting point and solubility in solvents like DMSO, is readily available on chemical industry platforms like ECHEMI and ChemicalBook, guiding its appropriate use.
The production of bulk drug intermediates is a specialized field that demands adherence to stringent quality control measures. Manufacturers must ensure that each batch of 2-Butyrylaminopropionic Acid meets specific purity requirements and consistent specifications. NINGBO INNO PHARMCHEM CO.,LTD. is committed to maintaining these high standards, recognizing that the quality of the intermediate directly influences the quality and safety of the final pharmaceutical product. Our manufacturing processes are designed for both efficiency and quality assurance.
The global demand for pharmaceutical intermediates like 2-Butyrylaminopropionic Acid is substantial, driven by the ever-growing pharmaceutical market. Sourcing this intermediate often involves extensive supplier vetting to ensure reliability, competitive pricing, and timely delivery. NINGBO INNO PHARMCHEM CO.,LTD. positions itself as a dependable partner, offering a stable supply chain and expert support for clients engaged in bulk drug intermediate production. Our understanding of market dynamics allows us to effectively meet the needs of the industry.
In summary, 2-Butyrylaminopropionic Acid is an indispensable compound in the realm of bulk drug intermediate production. Its role as a versatile chemical building block highlights the importance of reliable sourcing and high-quality manufacturing. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting the pharmaceutical industry by providing this critical intermediate, contributing to the consistent production of essential medicines worldwide.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.